• Explore /
  • Poster
  • / Frequency of brain metastases in patients with locally advanced triple negative breast cancer after neoadjuvant platinum-based chemotherapy: Impact of <em>BRCA1/2</em> mutations.

Frequency of brain metastases in patients with locally advanced triple negative breast cancer after neoadjuvant platinum-based chemotherapy: Impact of BRCA1/2 mutations.

Abstract Poster

Authors

null

Elena Glazkova

N.N. Blokhin National Medical Research Center of Oncology, St. Petersburg, Russian Federation

Elena Glazkova , Marina Stenina , Mona A. Frolova , Ekaterina Ignatova , Alexey Rumyantsev , Alexander Petrovsky , Sergei Tjulandin

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2020 ASCO Virtual Scientific Program

Session Type

Poster Session

Session Title

Breast Cancer—Metastatic

Track

Breast Cancer

Sub Track

Triple-Negative

Citation

J Clin Oncol 38: 2020 (suppl; abstr 1079)

DOI

10.1200/JCO.2020.38.15_suppl.1079

Abstract #

1079

Poster Bd #

164

Abstract Disclosures

Similar Posters

First Author: Xin Huang

Poster

2024 ASCO Genitourinary Cancers Symposium

SWOG S2210: A phase II study of neoadjuvant carboplatin for localized, high-risk prostate cancer with germline <em>BRCA1/2</em> mutations.

SWOG S2210: A phase II study of neoadjuvant carboplatin for localized, high-risk prostate cancer with germline BRCA1/2 mutations.

First Author: Heather H. Cheng

First Author: Sourat Darabi

First Author: Haven Garber